Background and Purpose-Light-to-moderate alcohol consumption has been associated with reduced risk of total and ischemic stroke. However, data on the relationship between alcohol consumption and functional outcomes from stroke are sparse. Methods-Prospective cohort study among 21 860 men enrolled in the Physicians' Health Study who provided information on alcohol consumption at baseline and had no prior history of stroke or transient ischemic attack (TIA). Alcohol consumption was divided into 5 categories: Ͻ1 drink/wk, 1 drink/wk, 2 to 4 drinks/wk, 5 to 6 drinks/wk, and Ն1 drink/d. Possible functional outcomes included TIA, modified Rankin Scale (mRS)ϭ0 to 1, mRSϭ2 to 3, and mRSϭ4 to 6. We used multinomial logistic regression to evaluate the relationship between levels of alcohol consumption and functional outcomes from stroke. Results-During a mean of 21.6 years of follow-up, 766 TIAs and 1393 strokes (1157 ischemic, 222 hemorrhagic, and 14 unknown type) occurred. Men who consumed 1 drink/wk had lowest associated odds for any outcome. Compared with men who did not experience a TIA or stroke and who consumed Ͻ1 drink/wk, men who consumed 1 drink/wk had odds ratio (95% CI) for total stroke of 0.85 (0.60 to 1.21) for mRSϭ0 to 1, 0.84 (0.64 to 1.10) for mRSϭ2 to 3, and 0.60 (0.37 to 0.97) for mRSϭ4 to 6. The odds ratio for TIA was 0.95 (0.73 to 1.23). The pattern of association did not substantially differ for ischemic and hemorrhagic stroke. Higher alcohol consumption showed no association with functional outcome after stroke. Conclusions-Our data do not show strong associations between alcohol consumption and functional outcome after stroke.
S
troke is one of the leading causes of disability and death worldwide and is expected to become a more prevalent cause of disability in the future because of the aging population. 1, 2 Several behavior dependent risk factors for stroke are established. Although single risk factors, such as smoking, were the target of earlier prevention campaigns, efforts to reduce stroke morbidity and mortality now often aim to influence individuals toward a more "healthy lifestyle." This approach is based on studies that found that the risk of total and ischemic stroke was significantly decreased with an increasing healthy lifestyle index score. 3, 4 Such an index is composed of behavior dependent lifestyle factors, such as smoking, physical activity, and includes alcohol consumption. Studies evaluating the single relationship between alcohol consumption and risk of stroke showed J-shaped associations between risk of total stroke and alcohol consumption. 3, 4 A meta-analysis found that consuming less than 1 drink per day was associated with a significantly reduced risk of stroke compared to nondrinkers. 5 Consumption of more than 5 drinks per day was associated with a significantly increased risk of stroke compared to nondrinkers. A previous analysis in the Physicians' Health Study (PHS) showed that men who consumed 2 to 4 alcoholic drinks per week had the lowest risk of total and ischemic stroke compared to men who consumed less than 1 alcoholic drink per week after an average of 12.2 years of follow-up. 6 Data on the association of alcohol consumption on functional outcome from stroke, however, are sparse. A few studies have examined factors that affect stroke morbidity, but none focused specifically on the association between alcohol consumption and short-term outcomes from stroke. 7, 8 Because of the large projected morbidity burden of stroke, finding factors that may reduce stroke morbidity is becoming increasingly important. In this study, we aimed to evaluate the relationship between alcohol consumption and risk of functional outcomes on hospital discharge after stroke.
Methods
The PHS was a randomized primary prevention trial of the effect of low-dose aspirin on cardiovascular disease and the effect of betacarotene on the risk of cancer. The design, methods, and results have been previously described. 9, 10 In brief, 22 071 US male physicians between the ages of 40 and 84 in 1982 who were free of a history of stroke, transient ischemic attack (TIA), myocardial infarction, and other major diseases were randomly assigned to receive aspirin, beta carotene, both active agents, or both placebos. After the end of the aspirin component in 1988 and the beta carotene component in 1995, the men continued to be followed either on an observational basis or as part of Physicians Health Study II. 11, 12 This analysis included data available as of March 2008. Morbidity and mortality follow-up is Ͼ99%. Informed consent was obtained from all participants and the institutional review board at Brigham and Women's Hospital approved the PHS.
Assessment of Exposure
Information on demographic and lifestyle characteristics and medical history was collected in yearly questionnaires. At baseline the participating physicians answered the question "How often do you usually consume alcoholic beverages (beer, wine, or liquor)?" The possible response categories were rarely or never, 1 to 3 per month, 1 per week, 2 to 4 per week, 5 or 6 per week, 1 per day, or 2 or more alcoholic drinks per day. 13 To be consistent with a previous study of alcohol consumption and risk of stroke in the PHS cohort, 6 we combined the alcohol consumption categories of rarely or never and 1 to 3 drinks per month to create one larger reference category. Additionally, we a priori combined the categories of 1 drink per day and 2 or more drinks per day to create 1 category (Ն1/d) according to previous categorization in the PHS. 6 
Assessment of Outcome
Every 6 months for the first year and annually thereafter, participants were sent a follow-up questionnaire asking about any newly diagnosed medical conditions, including stroke and TIA. For all reported trial outcomes events, permission was asked to review medical records. An end points committee of physicians confirmed all trial outcomes. A nonfatal stroke was defined as a focal neurological deficit with sudden or rapid onset attributable to a cerebrovascular event that lasted more than 24 hours. A TIA was defined as a focal-neurological deficit with sudden or rapid onset attributable to a cerebrovascular event that lasted less than 24 hours. If family members or postal authorities reported that the participant had died, the death was verified by reviewing all available medical records, death certificates, and eyewitness accounts. Stroke cases were further classified as ischemic, hemorrhagic, or unknown type with high interobserver agreement. 14 Medical record information was also used to determine the functional outcome from the stroke according to the modified Rankin scale (mRS). The mRS is a 6-point scale (0ϭno symptoms at all; 1ϭno significant disability despite symptoms; 2ϭslight disability; 3ϭmoderate disability; 4ϭmoderately severe disability; 5ϭsevere disability; 6ϭdeath). 15, 16 To avoid problems with model convergence because of sparse data, we a priori categorized the mRS score into 3 levels (0 to 1, 2 to 3, 4 to 6). 17 The possible functional outcomes were no stroke, TIA, and the 3 categories of the mRS. In the event that a participant experienced multiple strokes or TIAs, the only first event was used in our analysis.
Statistical Analysis
We excluded participants who were missing information on alcohol consumption (nϭ198), had missing mRS scores (nϭ2), or reported a stroke or TIA before receiving the baseline questionnaire (nϭ11), leaving a total of 21 860 men for this analysis.
We used Cox proportional hazards models to calculate the relative risk of TIA and total, ischemic, and hemorrhagic stroke for each level of alcohol consumption using the category of less than 1 drink per week as the reference. We tested the assumption of proportional hazards by including an interaction term between the log transformation of time on study and alcohol consumption category and found no significant violation.
We used multinomial logistic regression to evaluate the relationship between levels of alcohol consumption and functional outcomes from stroke. Multinomial logistic regression is an extension of binary logistic regression that allows the dependent variable to have more than 2 categories. Each category is then simultaneously compared to a reference category. We calculated odds ratios of each functional outcome according to level of alcohol consumption from the multinomial logistic regression model, using men in the less than 1 drink per week category who did not experience a stroke or TIA as the reference group. For the analyses examining the relationship between alcohol consumption and functional outcome after hemorrhagic stroke, TIA was not included as a potential outcome.
We distinguished 2 multivariable models for both our risk of stroke and functional outcomes from stroke analyses. The first model controlled for age, randomized treatment assignments, systolic blood pressure, smoking, body mass index, exercise, history of diabetes, current treatment for hypertension, and history of migraine, variables that we believed could be confounders based on plausible biological mechanisms. In a second model, we included variables that are potential intermediates on the causal pathway between alcohol consumption and functional outcome from stroke. These variables were diastolic blood pressure, history of hypertension, history of high cholesterol, and cholesterol medication use.
Finally, we examined whether age, cigarette use, obesity, history of hypertension, or randomized assignment to aspirin modified the relationship between alcohol consumption and risk of total stroke or functional outcomes from total stroke by including an interaction term between alcohol consumption and each variable in separate models.
For all models, we included an indicator variable for variables that had Ͼ100 missing (exercise, migraine history, history of hypertension, hypertension medication use, history of high cholesterol, and cholesterol medication use). We created a separate category for those missing information on systolic and diastolic blood pressure. Less than 100 men were missing information on history of diabetes, smoking, and body mass index and were assigned to no history of diabetes, past smoking, and the mean body mass index, respectively in our analysis. All statistical analyses were performed using SAS 9.1. All probability values are 2-tailed, and we considered PϽ0.05 as statistically significant. Table 1 summarizes the baseline characteristics of the 21 860 participants according to categories of alcohol consumption. Men who drank 1 or more alcoholic drinks per day were slightly older and were more likely to have a history of hypertension than the men in the other categories of alcohol consumption. The percentage of men who were never smokers decreased with increasing alcohol intake. The percentage of men with a history of migraine or diabetes was highest in among the men who drank less than 1 alcoholic drink per week.
Results

Risk of Stroke
During a mean of 21.6 years of follow-up (473 035 person years) a total of 766 TIAs and 1393 strokes (1157 ischemic strokes, 222 hemorrhagic strokes, and 14 strokes of unknown type) occurred. Table 2 shows the relative risk of total, ischemic, and hemorrhagic stroke and TIA by level of alcohol consumption. Compared to the less than 1 drink per week category, the lowest risk of total, ischemic, and hemorrhagic stroke was observed for the 1 drink per week category. Only the decrease in total stroke risk among men who consumed 1 drink per week compared to less than 1 drink per week reached statistical significance (relative riskϭ0.80, 95% CI: 0.66, 0.97; Pϭ0.03). No level of alcohol consumption resulted in a statistically significant increased risk of TIA or ischemic or hemorrhagic stroke. Adjusting for potential intermediates had very little impact on our results (results not shown). Stratified analyses to test as to whether age, cigarette use, obesity, history of hypertension, and randomized assignment to aspirin modified the relationship between alcohol consumption and risk of total stroke did not show any significant interaction between these variables and alcohol consumption (all PϾ0.05).
Functional Outcomes From Stroke
The association of alcohol consumption with functional outcomes from stroke after adjusting for possible confounders is summarized in Table 3 . Men who consumed 1 drink per week had lowest associated risk for any of the outcomes. With regard to total stroke, compared with men who did not experience a TIA or stroke and who consumed less than 1 drink per week, men who consumed 1 drink per week had a relative risk (95% CI) 0.85 (0.60 to 1.21) for mRSϭ0 to 1, 0.84 (0.64 to 1.10) for mRSϭ2 to 3, and 0.60 (0.37 to 0.97) for mRSϭ4 to 6. Higher alcohol consumption showed no association with functional outcome after stroke. Using less than 1 drink per week as the reference group, no level of increased alcohol consumption resulted in a statistically significant increase or decrease in the risk of TIA compared to the reference group (relative risk (95% confidence interval) Numbers may not add up to 100% because of rounding or missing data. *History of hypertension was defined as self-reported systolic blood pressure of 140 mm Hg or higher, diastolic blood pressure 90 mm Hg or higher, or past or current treatment for hypertension (regardless of blood pressure). †History of high cholesterol was defined as blood cholesterol 240 mg/100 mL or higher or past or current cholesterol medication. The pattern of association with the mRS was similar for ischemic stroke (Table 3) . No clear pattern was observed between alcohol consumption and functional outcomes from hemorrhagic stroke (Table 3) .
We found no significant effect modification between age, cigarette use, obesity, history of hypertension, or randomized assignment to aspirin on the relationship between alcohol consumption, and functional outcomes from total stroke (all PϾ0.10).
Discussion
Data from this large prospective cohort study in men do not support a strong association between alcohol consumption and risk of incident stroke or functional outcome after stroke. Our data suggest lowest risks of incident TIA and total, ischemic or hemorrhagic stroke among men who consume 1 alcohol drink per week. However, this decrease in risk only reached statistical significance for total stroke. When examining the relationship between alcohol consumption and short-term functional outcomes after stroke, most of the categories of alcohol consumption did not show a statistically significant association with functional outcomes after stroke. Only men who consumed 1 drink per week had a significantly decreased risk of having an mRS score of 4 to 6 (ie, the most Comparison group consists of men without stroke or transient ischemic attack (TIA) who consumed Ͻ1 drink/wk alcohol. mRS indicates modified Rankin Scale; CI, confidence interval. *Adjusted for age, systolic blood pressure, treatment for hypertension, smoking, history of diabetes, body mass index, exercise, history of migraine, and TIA.
severely affected group) as compared with men who had no stroke or TIA and who consumed less than 1 drink per day. Our results with regard to the association between alcohol consumption and stroke incidence are somewhat different from those found in an earlier study of the relationship between alcohol consumption and risk of stroke using PHS data. 6 Berger et al found that men who consumed 2 to 4 alcohol drinks per week had a statistically significant decreased risk of total and ischemic stroke. The differences in the results between our study and Berger's study and other studies that have also shown statistically significant decreased risk of stroke among light to moderate drinkers 18, 19 may be explained by the longer follow-up time and, thus, the aging of the cohort. Moderate to light alcohol consumption may reduce the risk of stroke in shorter follow-up periods but has reduced influence in long periods.
Only a few studies have looked at the effect of prestroke alcohol consumption on functional stroke outcomes. The North East Melbourne Stroke Incidence Study (NEMESIS) did not find prestroke alcohol consumption to be a factor that independently predicted handicap 2 years after stroke in multivariate analysis. 8 The Copenhagen Stroke Study examined a population of patients with severe stroke to determine factors that predicted good outcome after rehabilitation. Daily alcohol consumption compared to nondaily alcohol consumption was an independent predictor of good outcome only in univariate but not in multivariate analysis. 7 Our study shows similar results to NEMESIS and the Copenhagen Stroke Study and extends their findings because the large number of participants and outcome events allow us to use finer categories of alcohol consumption and functional stroke outcome. Additionally, our results are not limited to only the most severe cases of stroke.
We used the mRS scores as a measurement of functional outcome from stroke. Although the mRS claims to be a measure of handicap, its strong emphasis on mobility makes it more a measure of disability or a "global health index." 20, 21 Despite its limitations, 22, 23 the mRS score is widely accepted for use in clinical trials and is an appropriate outcome measure for this study. The mRS is simple to administer, can be assessed retrospectively from medical records, and has strong test-retest reliability, interrater reliability, and validity. 23 Additionally, the mRS can be used to compare patients with many different types of neurological limitations and allows prestroke disability to be taken into consideration when determining poststroke Rankin score. 15 Another advantage to mRS is that it does not seem to have a "ceiling effect" as can sometimes be observed when using the Barthel Index. 24 Other strengths to our study include the large number of participants and outcome events, prospective design, confirmed outcome definition with high interobserver agreement, 14 and the homogenous structure of the cohort, which limits confounding by access to medical care.
One limitation to our study is the possible bias arising from the use of self-reported alcohol consumption. However, misclassification of alcohol consumption at baseline is most likely nondifferential because of the prospective design. Only using alcohol consumption at baseline may not accurately reflect alcohol consumption over the course of the study. However, we found a high correlation between alcohol consumption at baseline and at 84 months (rϭ0.75). In addition, when we evaluated the association between alcohol consumption and risk of stroke and functional outcomes from stroke using alcohol consumption at 84 months and cases of stroke after 84 months, we found very similar results (data not shown). We combined the 2 highest alcohol intake categories because only a few physicians drank Ͼ1 drink per day, which may have masked potential harmful effects. However, dividing the highest category of alcohol consumption (Ն1 drink/d) into 2 categories (1 drink/d and Ն2 drinks/d) did not reveal any further increased or decreased risk of our functional outcomes (data not shown).
Using nondrinkers as the reference category when examining the relationship between alcohol consumption and risk of stroke or functional outcomes from stroke has been questioned because of the potential for ex-drinkers who quit for health reasons to be included in the nondrinkers category. Including ex-drinkers in the nondrinker category may result in an attenuation of the relationship between alcohol consumption and risk of stroke or functional outcomes from stroke. However, the inclusion of many ex-drinkers in the nondrinker category is unlikely in this cohort because the men were free of many disabling conditions and of major diseases at baseline that could lead one to abstain from alcohol.
Having limited information about the men's functional status prestroke is unlikely to be a large source of bias. In general the men were most likely healthy and able-bodied because they had to be free of many major diseases to be included in the study base. Additionally, the mRS scale takes prestroke disability into account when measuring functional outcomes from stroke.
Another limitation is that because very few men in our study were underweight, we are unable to make any inferences about possible interactions between body weight and alcohol consumption on our functional outcomes.
Our study participants were all male physicians who presumably live a healthier lifestyle compared to the general population. Thus, our results may not be generalizable to other populations and we cannot exclude potential harmful effects of very high alcohol consumption on the evaluated outcomes. Because gender differences in alcohol metabolism may exist 25 and women have different risk factors for stroke and poorer outcomes from stroke than men, 26 future research will need to examine the association of alcohol consumption on the risk of stroke and functional outcomes from stroke among women.
In conclusion, our data do not show strong association between alcohol consumption, which is a component of the lifestyle of many individuals, with risk of incident stroke or functional outcome after stroke. A modest beneficial association was observed for those men who had low alcohol consumption. Future studies are warranted to evaluate potential factors influencing functional outcome after stroke.
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